291 related articles for article (PubMed ID: 33059617)
1. French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long.
Brouard C; Pillonel J; Boussac M; de Lédinghen V; Rachas A; Silvain C; Lydié N; Chevaliez S; Pioche C; Durand J; Lot F; Delarocque-Astagneau E
BMC Infect Dis; 2020 Oct; 20(1):759. PubMed ID: 33059617
[TBL] [Abstract][Full Text] [Related]
2. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
[TBL] [Abstract][Full Text] [Related]
3. Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
Litzroth A; Suin V; Wyndham-Thomas C; Quoilin S; Muyldermans G; Vanwolleghem T; Kabamba-Mukadi B; Verburgh V; Jacques M; Van Gucht S; Hutse V
BMC Public Health; 2019 Jan; 19(1):39. PubMed ID: 30621662
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
Cousien A; Tran VC; Deuffic-Burban S; Jauffret-Roustide M; Mabileau G; Dhersin JS; Yazdanpanah Y
J Viral Hepat; 2018 Oct; 25(10):1197-1207. PubMed ID: 29660211
[TBL] [Abstract][Full Text] [Related]
5. Planning the hepatitis C virus elimination in Cyprus: A modeling study.
Gountas I; Yiasemi I; Kyprianou E; Mina C; Georgiou C; Katsioloudes P; Kouroufexi A; Demetriou A; Xenofontos E; Nikolopoulos G
World J Gastroenterol; 2021 Aug; 27(31):5219-5231. PubMed ID: 34497446
[TBL] [Abstract][Full Text] [Related]
6. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
7. Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.
Chen Q; Ayer T; Bethea E; Kanwal F; Wang X; Roberts M; Zhuo Y; Fagiuoli S; Petersen J; Chhatwal J
BMJ Open; 2019 Jun; 9(6):e026726. PubMed ID: 31189677
[TBL] [Abstract][Full Text] [Related]
8. HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy.
Brouard C; Saboni L; Gautier A; Chevaliez S; Rahib D; Richard JB; Barin F; Larsen C; Sommen C; Pillonel J; Delarocque-Astagneau E; Lydié N; Lot F;
BMC Infect Dis; 2019 Oct; 19(1):896. PubMed ID: 31660879
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
[TBL] [Abstract][Full Text] [Related]
10. The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.
Cousien A; Leclerc P; Morissette C; Bruneau J; Roy É; Tran VC; Yazdanpanah Y; Cox J
BMC Infect Dis; 2017 Feb; 17(1):162. PubMed ID: 28222681
[TBL] [Abstract][Full Text] [Related]
11. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
[TBL] [Abstract][Full Text] [Related]
12. Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis.
Yousafzai MT; Bajis S; Alavi M; Grebely J; Dore GJ; Hajarizadeh B
J Viral Hepat; 2021 Oct; 28(10):1340-1354. PubMed ID: 34310812
[TBL] [Abstract][Full Text] [Related]
13. [Elimination of hepatitis C virus in Denmark].
Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
[TBL] [Abstract][Full Text] [Related]
14. Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
Serumondo J; Penkunas MJ; Niyikora J; Ngwije A; Kiromera A; Musabeyezu E; Umutesi J; Umuraza S; Musengimana G; Nsanzimana S
BMC Public Health; 2020 Jun; 20(1):946. PubMed ID: 32546216
[TBL] [Abstract][Full Text] [Related]
15. Strategy for the Elimination of Hepatitis C in Cantabria.
Crespo J; Tejerina Puente A; Cuadrado A; Llerena S; Cabezas J;
Rev Esp Enferm Dig; 2020 Jul; 112(7):565-570. PubMed ID: 32543873
[TBL] [Abstract][Full Text] [Related]
16. Real-world economic burden of hepatitis C and impact of direct-acting antivirals in France: A nationwide claims data analysis.
Lam L; Carrieri P; Hejblum G; Bellet J; Bourlière M; Carrat F
Liver Int; 2024 May; 44(5):1233-1242. PubMed ID: 38375961
[TBL] [Abstract][Full Text] [Related]
17. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
[TBL] [Abstract][Full Text] [Related]
18. Continuum of hepatitis C care in France: A 20-year cohort study.
Hermetet C; Dubois F; Gaudy-Graffin C; Bacq Y; Royer B; Gaborit C; D'Alteroche L; Desenclos JC; Roingeard P; Grammatico-Guillon L
PLoS One; 2017; 12(8):e0183232. PubMed ID: 28850623
[TBL] [Abstract][Full Text] [Related]
19. The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.
Willemse SB; Razavi-Shearer D; Zuure FR; Veldhuijzen IK; Croes EA; van der Meer AJ; van Santen DK; de Vree JM; de Knegt RJ; Zaaijer HL; Reesink HW; Prins M; Razavi H
Neth J Med; 2015 Nov; 73(9):417-31. PubMed ID: 26582807
[TBL] [Abstract][Full Text] [Related]
20. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.
Wang AE; Hsieh E; Turner BJ; Terrault N
J Gen Intern Med; 2022 Oct; 37(13):3435-3443. PubMed ID: 35484367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
